Navigation Links
Reportlinker Adds Opportunities in Non-Surgical Bio-Implants: Marketed injectable biomaterials, applications, and leading players
Date:7/6/2010

This report provides a comprehensive assessment and analysis of the current market for viscoaugmentation and viscosupplementation products and shows how research and development has expanded product choice and diversity among the relatively limited injectable medical devices that are approved.

The report also shows promising next-generation bio-implants and those in preclinical research and clinical development. It details the challenges of achieving biocompatibility and the technologies that have successfully emerged from biomaterials research. Additionally, the report details the major players, market opportunities, and emerging sectors of the field that are changing the landscape of injectable treatments with major applications in cosmetic dermatology and orthopedics. The report also shows how reformulation and product line extensions may be needed to succeed in an increasingly saturated market sector.

Key features of this report

  • Analysis of current biomaterials that have been developed as injectable medical devices
  • Evaluation of the barriers and problems associated with biocompatibility for developed biomaterial types
  • Identification of the current trends in injectable bio-implants for aesthetic and medical indications and how companies have expanded indications to increase revenues and portfolios
  • Analysis of next-generation products and how companies are reformulating products to improve clinical performance and patient attractiveness.
  • Assessment of approved injectable viscoaugmentation and viscosupplementation devices and the strategies employed to expand product lines

Scope of this report

  • Understanding of the key obstacles in
    '/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... ® Technologies, Inc., the leader in non-invasive, accelerated orthodontic ... to continued demand from orthodontists and patients for safe, ... locations in the U.S. and Canada ... the only FDA-cleared Class II medical device that has ... much as 50 percent.  A recent ...
(Date:5/26/2015)... NEW YORK , May 26, 2015 /PRNewswire/ ... that Jennifer Simpson , Ph.D., M.S.N., C.R.N.P. ... by the Company,s Board of Directors, effective immediately.  ... Chief Executive Officer of Delcath since September 2014 ... from September 2013 to September 2014.  She joined ...
(Date:5/26/2015)... 26, 2015  LabStyle Innovations Corp. (DRIO), ... announced today that in partnership with ... Healthcare, it has launched  the comprehensive Dario™ ... advanced Telecare unit (MOMA). The Dario™ is ... enables remote treatment for diabetes aiming to ...
Breaking Medicine Technology:OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 2OrthoAccel Technologies Continues Trajectory of Accelerated Growth with Over 2,500 Practice Locations 3Delcath Names Dr. Jennifer Simpson President And CEO 2Delcath Names Dr. Jennifer Simpson President And CEO 3Delcath Names Dr. Jennifer Simpson President And CEO 4LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 2LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 3LabStyle Innovations and Maccabi Healthcare Launch Dario Platform for Remote Treatment of Diabetes in Israel 4
... study broadens Phase 3 clinical program to further evaluate the ... April 15 Pfizer (NYSE: PFE ) and ... announced the initiation of a 12-month, Phase 3 clinical trial ... CONCERT, is designed to evaluate the safety and efficacy of ...
... Pharmacyclics, Inc.,(Nasdaq: PCYC ) today announced that ... study to evaluate the safety and tolerability of PCI-32765,an ... Btk,as a potential treatment for patients with relapsed or ... first Btk selective inhibitor to,be tested in humans, and ...
Cached Medicine Technology:Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 2Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 3Pfizer and Medivation Initiate Phase 3 Trial of Dimebon Added to Donepezil in Patients with Alzheimer's Disease 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 2Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 3Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 4Pharmacyclics Initiates Phase 1 Clinical Trial of Novel Oral Btk Inhibitor for Refractory B-cell Non-Hodgkin's Lymphoma 5
(Date:5/26/2015)... Neeta Pai was diagnosed with HHT ... spells, four of which landed her in the emergency ... , Though she still struggles with anemia, iron deficiency ... time to increasing HHT awareness and garnering support for ... we could have prevented all the heartbreak and trauma ...
(Date:5/26/2015)... Sexual harassment and sexual assault are major ... known for creating opportunities in women's athletics, it is now ... and prevention. In a recent episode of SCI TV ... explains what Title IX means for university administrators dealing with ... this issue to protect students. , In the last 15 ...
(Date:5/26/2015)... senior industry executives are expected at the Suburban Collection ... connected car. A very special attraction for the clear-headed ... driver’s brain waves. Visitors to its booth will be ... just by gripping the steering wheel! , Peter Freer, ... cognitive load, altering music based on the driver’s mood, ...
(Date:5/26/2015)... 26, 2015 Relias Learning , ... the health and human services market, announces expansion of ... After strong attendance and participation in 2014, they will ... their annual user conference an exciting new facelift. ... come together and discuss best practices, share their expertise, ...
(Date:5/26/2015)... Mr. Larry Westenberg is a Licensed ... Programming, or NLP. Mr. Westenberg is recently also ... or RRT®. While many people have learned small ... to specific areas, Mr. Westenberg has been studying the ... years. He works with people suffering the effects ...
Breaking Medicine News(10 mins):Health News:Rochester Woman Brings Awareness to Genetic Disease 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 2Health News:Paul Greene Explores Title IX and College Sports on SCI TV 3Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 2Health News:The World’s Biggest Connected Car Exhibition is Back in Detroit 3Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3
... Re-elect Directors, Ratify E&Y and Approve Charter Amendment; ... Board Re-appoints Leadership, ... the "Company") said today that its Board of Directors declared,a regular ... 2008 to stockholders of record on June 4, 2008. The dividend ...
... Calif., May 19 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... S.,Williams has rejoined the company in a ... a wholly owned subsidiary of Alexza. Mr.,Williams ... Alexza,subsidiary in Singapore and establishing potential joint ...
... VALLEY FORGE, Pa., May 19 The St. Jude ... first drywall ever manufactured at the,new CertainTeed Gypsum Plant ... for St. Jude Children,s Research Hospital, CertainTeed is,donating gypsum ... the,house., (Logo: http://www.newscom.com/cgi-bin/prnh/20070102/CLTU053LOGO ), The ...
... Provides Development Expertise for Partners ... Developing on the Google Health Platform, PORTLAND, Ore., May ... and development company, announced,collaboration today with Google as a development ... to the public at an,event at Google,s headquarters today; the ...
... Program seeks to advance knowledge of mysterious conditions , , ... program designed to help patients with mysterious health conditions ... U.S. National Institutes of Health. , The Undiagnosed Diseases ... to the NIH Clinical Center by doctors across the ...
... of Nebraska Medical Center-led pilot study that showed antidepressants ... and neck cancer patients is the focus of an ... one of the publications produced by the Journal of ... led by UNMCs William Lydiatt, M.D., and Bill Burke, ...
Cached Medicine News:Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 2Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 3Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 4Health News:Ventas Declares Regular Quarterly Dividend of $0.5125 Per Share 5Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 2Health News:Jeffrey S. Williams Rejoins Alexza Pharmaceuticals as President, Alexza Singapore Pte. Ltd. 3Health News:Gypsum Wallboard from CertainTeed's Moundsville, W. Va., Plant and Roofing Shingles among Building Materials Donated to St. Jude Dream Home(R) 2Health News:Mount Tabor Collaborates with Google Health 2Health News:U.S. Turns Spotlight on Medicine's Most Puzzling Cases 2Health News:JAMA publication features study on depression and head and neck cancer 2
This standard tying forcep is curved with 5mm titanium coated platforms. Length 85 mm....
Catalano curved tying forcep has 6 mm V-grove tying platform. Overall length 100 mm....
Kelman - McPherson tying forceps with serrated handle, platform 4 mm and overall length of 85 mm....
Troutman tying forceps are curved, delicate, bullet shape, with tying platforms. Flat pattern. Ultra fine platforms ideal for 10-0 or 11-0 suture material. Platforms fully meet to hold suture firmly....
Medicine Products: